Cargando…

Dysregulated circular RNAs are closely linked to multiple myeloma prognosis, with circ_0026652 predicting bortezomib-based treatment response and survival via the microRNA-608-mediated Wnt/β-catenin pathway

Circular RNA (circRNA/circ) profiles have been suggested to be involved in the prognosis of several types of solid tumors and hematological malignancies, including multiple myeloma (MM). Therefore, the aim of the present study was to comprehensively explore the involvement of circRNA profiles in MM...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Lu, Liu, Jin, Du, Juan, Jiang, Hua, He, Haiyan, Jing, Lu, Qiang, Wanting, Hou, Nan, Guo, Pei, Zhuang, Yan, Fu, Weijun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9535628/ https://www.ncbi.nlm.nih.gov/pubmed/36129153 http://dx.doi.org/10.3892/or.2022.8410

Ejemplares similares

Effect of bortezomib on proliferation and apoptosis of myeloma cells by activating Wnt/β-catenin signaling pathway
por: Dai, Yanling, et al.
Publicado: (2020)

β-catenin inhibitors ICG-001 and pyrvinium sensitize bortezomib-resistant multiple myeloma cells to bortezomib
por: Wu, Cuicui
Publicado: (2022)

Synergistic Efficacy of the Demethylation Agent Decitabine in Combination With the Protease Inhibitor Bortezomib for Treating Multiple Myeloma Through the Wnt/β-Catenin Pathway
por: Jin, Yulong, et al.
Publicado: (2019)

CircATRNL1 and circZNF608 Inhibit Ovarian Cancer by Sequestering miR-152-5p and Encoding Protein
por: Lyu, Mengmeng, et al.
Publicado: (2022)

Circular RNA circRNA_0067934 promotes glioma development by modulating the microRNA miR-7/ Wnt/β-catenin axis
por: Pei, Yunlong, et al.
Publicado: (2022)

Circulating Exosomal CircMYC Is Associated with Recurrence and Bortezomib Resistance in Patients with Multiple Myeloma
por: Luo, Yanwei, et al.
Publicado: (2020)

Translation of the circular RNA circβ-catenin promotes liver cancer cell growth through activation of the Wnt pathway
por: Liang, Wei-Cheng, et al.
Publicado: (2019)

Hsa_circ_0087302, a circular RNA, affects the progression of osteosarcoma via the Wnt/β-catenin signaling pathway
por: Peng, Lijiao, et al.
Publicado: (2022)

Wnt expression is not correlated with β-catenin dysregulation in Dupuytren's Disease
por: O'Gorman, David B, et al.
Publicado: (2006)

Mechanisms underlying synergism between circularized tumor necrosis factor‐related apoptosis inducing ligand and bortezomib in bortezomib‐sensitive or ‐resistant myeloma cells
por: Leng, Yun, et al.
Publicado: (2022)

Bortezomib in the management of multiple myeloma
por: Laubach, Jacob P, et al.
Publicado: (2009)

Circular RNA circβ‐catenin aggravates the malignant phenotype of non‐small‐cell lung cancer via encoding a peptide
por: Zhao, Weijun, et al.
Publicado: (2021)

Circular RNA circ_0068464 combined with microRNA-383 regulates Wnt/β-catenin pathway to promote the progression of colorectal cancer
por: Zou, Yan, et al.
Publicado: (2022)

The Anticancer Effect of Napabucasin (BBI608), a Natural Naphthoquinone
por: Shao, Zeyang, et al.
Publicado: (2023)

Wnt inhibitors reduce the unfolded protein response and enhance bortezomib-induced cell death in multiple myeloma
por: Spaan, Ingrid, et al.
Publicado: (2022)

Circular RNA ITCH has inhibitory effect on ESCC by suppressing the Wnt/β-catenin pathway
por: Li, Fang, et al.
Publicado: (2015)

Bortezomib (Velcade™) in the Treatment of Multiple Myeloma
por: Field-Smith, Antonia, et al.
Publicado: (2006)

Biological Functions and Molecular Mechanisms of MiR-608 in Cancer
por: Lu, Juan, et al.
Publicado: (2022)

Anthelmintic pyrvinium pamoate blocks Wnt/β-catenin and induces apoptosis in multiple myeloma cells
por: Xu, Fang, et al.
Publicado: (2020)

Human Cytomegalovirus Infection Dysregulates the Canonical Wnt/β-catenin Signaling Pathway
por: Angelova, Magdalena, et al.
Publicado: (2012)

Circular RNA Hsa_circ_0004018 Inhibits Wnt/β-Catenin Signaling Pathway by Targeting microRNA-626/DKK3 in Hepatocellular Carcinoma
por: Zhu, Pengfei, et al.
Publicado: (2020)

Bortezomib potentiates antitumor activity of mitoxantrone through dampening Wnt/β-catenin signal pathway in prostate cancer cells
por: Zhang, Ying, et al.
Publicado: (2021)

Nelfinavir augments proteasome inhibition by bortezomib in myeloma cells and overcomes bortezomib and carfilzomib resistance
por: Kraus, M, et al.
Publicado: (2013)

Development and validation of prognostic implications of chromosome abnormalities algorithm for newly diagnosed multiple myeloma
por: Luo, Tiancheng, et al.
Publicado: (2020)

Clinical outcomes of bortezomib-based therapy in myeloma
por: Djebbari, Faouzi, et al.
Publicado: (2018)

Bortezomib Treatment Modulates Autophagy in Multiple Myeloma
por: Di Lernia, Giuseppe, et al.
Publicado: (2020)

Entinostat-Bortezomib Hybrids against Multiple Myeloma
por: Ferro, Angelica, et al.
Publicado: (2023)

Knockdown of Circular RNA hsa_circ_PVT1 Inhibited Laryngeal Cancer Progression via Preventing wnt4/β-Catenin Signaling Pathway Activation
por: Yu, Feng, et al.
Publicado: (2021)

Circ_SMAD4 promotes gastric carcinogenesis by activating wnt/β‐catenin pathway
por: Wang, Liyan, et al.
Publicado: (2021)

The Applicability of the International Staging System in Chinese Patients with Multiple Myeloma Receiving Bortezomib or Thalidomide-Based Regimens as Induction Therapy: A Multicenter Analysis
por: Lu, Jing, et al.
Publicado: (2015)

Diagnostic Role of Dysregulated Circular RNA hsa_circ_0036722 in Laryngeal Squamous Cell Carcinoma
por: Guo, Yang, et al.
Publicado: (2020)

Expression of circ_001569 is upregulated in osteosarcoma and promotes cell proliferation and cisplatin resistance by activating the Wnt/β-catenin signaling pathway
por: Zhang, Hongfei, et al.
Publicado: (2018)

Circular RNA circLMO7 acts as a microRNA-30a-3p sponge to promote gastric cancer progression via the WNT2/β-catenin pathway
por: Cao, Jiacheng, et al.
Publicado: (2021)

Memorandum: clarification of R608 triggering requirements
por: Diamant-Berger, Alain M, et al.
Publicado: (1979)

R608 at intersection I6, ISR
Publicado: (1980)

Dysregulation of sphingolipid metabolism contributes to bortezomib-induced neuropathic pain
por: Stockstill, Katherine, et al.
Publicado: (2018)

Long-term outcomes of different bortezomib-based regimens in Chinese myeloma patients
por: Wang, Hua, et al.
Publicado: (2016)

Arsenic sulfide inhibits the progression of gastric cancer through regulating the circRNA_ASAP2/Wnt/β-catenin pathway
por: Hu, Jing, et al.
Publicado: (2021)

Bortezomib: the evidence of its clinical impact in multiple myeloma
por: Lancaster, Simon
Publicado: (2006)

Subcutaneous bortezomib for multiple myeloma treatment: patients’ benefits
por: Petrucci, Maria Teresa, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_vhbu515am0us1t4ijk39cjm0m6